AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Announcement Under Regulation 30 - Updates
CoSara Diagnostics Private Limited, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises Limited has received Test License from CDSCO to manufacture corona virus (COVID-19) diagnostic test kits. Ambalal Sarabhai Enterprises Ltd - 500009 - Appointment of Company Secretary and Compliance Officer
With reference to the above mentioned subject, we hereby inform you that the Board of Directors at its Meeting held on February 13, 2020 has appointed Mr. Damodar Sejpal as Company Secretary and Compliance Officer of the Company with effect from March 14, 2020, pursuant to Section 203 of the Companies Act, 2013 and Regulation 6(1) of the Listing Regulations. Ambalal Sarabhai Enterprises Ltd - 500009 - Announcement Under Regulation 30 Of SEBI (LODR)- Updates
Synbiotics Limited, a Wholly Owned Subsidiary of Ambalal Sarabhai Enterprises Limited manufacturing company producing fermentation based Active Pharmaceutical Ingredients and one of the few Amphotericin B manufacturing facility in the world and the only manufacturing facility in India has successfully cleared The United States Food and Drug Administration (USFDA) inspection consecutively 5th time for GMP compliance without any regulatory actions. Ambalal Sarabhai Enterprises Ltd - 500009 - Outcome Of The Board Meeting Held On 13.02.2020
we are pleased to inform you that the Board of Directors of the Company in their meeting held on 13th February 2020, has approved and taken on record: 1. the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended on 31st December 2019 along with Limited Review Report of Auditors; 2. Mr. Ketan Adhvaryu (ICSI Membership No.: A6539), Company Secretary and Compliance Officer of the Company is retiring with effect from 13th March, 2020. Consequent to his retirement, he ceases to be Key Managerial Personnel of the Company. 3. Mr. Damodar Sejpal (ICSI Membership No. F7535) is appointed as Company Secretary and Compliance Officer of the Company with effect from 14th March, 2020. Consequent to his appointment, he will be Key Managerial Personnel of the Company. Ambalal Sarabhai Enterprises Ltd - 500009 - Results-Financial Results For The Quarter And Nine Months Ended On 31.12.2019
Pursuant to Regulations 30 & 33 of Chapter IV read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the Company in their meeting held on 13th February 2020, has approved and taken on record the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended on 31st December 2019. In this regard, please find enclosed herewith the following: A. Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended on 31st December 2019; and B. Limited Review Report issued by the Statutory Auditors of the Company. You are requested to take the Unaudited Financial Results on your record AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Board Meeting Intimation for Intimation Of Board Meeting
AMBALAL SARABHAI ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2020 ,inter alia, to consider and approve Intimation of next meeting of the Board of Directors of the Company to be held on Thursday, 13th February, 2020, interalia, to consider and take on record the Unaudited Financial Results of the Company (Standalone and Consolidated) together with Limited Review Report of Auditors for the quarter ended 31st December, 2019. The Audit Committee Meeting of the Company will be held on the same day. AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Closure of Trading Window
Pursuant to clause 4 of the Schedule B of the SEBI (Prohibition of Insider Trading) Regulation, 2015 vide Notification No.: EBI/LAD-NRO/GN/2018/59 dated December 31, 2018 i.e. the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and further clarification provided by the BSE Limited and National Stock Exchange of India limited vide their respective Circulars: LIST/COMP/01/2019-20 and NSE/CML/2019/11 dated April 02, 2019, the 'Trading Window' for dealing in securities of the Company by the Designated employees and their immediate relatives remain closed from February 05, 2020 till 48 hours after the declaration of the financial results for the quarter ended on December 31, 2019. Ambalal Sarabhai Enterprises Ltd - 500009 - Announcement under Regulation 30 (LODR)-Demise
We regret to inform you of the sudden and sad demise of Mr. Govinddas Zalani, Non-Executive Independent Director of the Company, on Saturday, February 1, 2020. Mr. Govinddas Zalani''s sudden and unexpected passing away will be an irreparable loss to the Company and all the directors and employees of the Company convey deep sympathy, sorrow and condolences. Ambalal Sarabhai Enterprises Ltd - 500009 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a confirmation certificate received from MCS Share Transfer Agent Limited, the Registrar and Transfer Agent of the Company for the period ended on 31st December, 2019. Ambalal Sarabhai Enterprises Ltd - 500009 - Shareholding for the Period Ended December 31, 2019
Ambalal Sarabhai Enterprises Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here